Posts Tagged ‘SARS-CoV-2’

How much easier would you breathe with the confidence that the air purifier in your office was hospital-grade and ready to eliminate the airborne virus that causes COVID-19? What if you knew you were providing critical protection across your entire facility – from production lines, to storage, to transport trucks, and beyond?

Airocide is the hospital-grade air purifier that can be installed in any space in your business – giving you a system proven to reduce the airborne coronavirus that causes COVID-19, SARS-CoV-2, lessening the risk to anyone in your facility. There are Airocide units equipped to handle multiple environments, with real-world use cases that include hospitals, restaurants, offices, warehouses, and much more. Discover what makes Airocide so powerful and versatile, and how you can protect your employees, visitors, and yourself with hospital-grade air purification.

What’s in Hospital-Grade Air Purification?

Clean air should mean just that – clean air. Airocide air purification produces no harmful emissions, as some other purifiers do. There’s no ozone and no peroxide, because Airocide purifiers use a technology designed for some of the most sensitive manmade environments of all. Photocatalytic oxidation (PCO), the technology in every Airocide unit, was designed by NASA to be deployed on the space station. The PCO in Airocide uses a sealed bioreactor to destroy pathogens and unwanted airborne compounds without producing harmful emissions. Now, Airocide can be found safely scrubbing the air in all kinds of environments here on earth – including sensitive medical facilities.

Systems Designed for Your Facility

Airocide isn’t just for the small, sealed compartments of the space station, though – PCO is an exceptionally adaptable, hospital-grade air purifier technology that can help protect against the virus that causes COVID-19 in spaces of any size. Imagine visitors who can come and go with confidence, employees working or enjoying the break room and common areas worry-free, and even just the relief you’ll get from a lower risk of airborne illnesses, both major and minor, throughout your facility. It’s all possible because the bioreactor, which forms the basis of PCO’s purification capabilities, can be expanded and modified. There are Airocide units adapted for greater throughput, a more thorough first-pass viral kill, and for higher-volume processing.

Discover the Air Purification Solution for Your Business

The right hospital-grade air purifier system will provide protection from the coronavirus that causes COVID-19 no matter the size of your facility. Airocide meets the standard for medical 

A new study has shown that Airocide air purifiers can eliminate SARS-CoV-2, the novel coronavirus that causes COVID-19. In 2020, the World Health Organization designated the outbreak of COVID-19 a global pandemic, and we’ve been working to determine how effective the photocatalytic oxidation (or PCO) and filtration technology inside Airocide is at fighting this virus. The results from a recent study show serious promise – with up to a 99.94% reduction of the SARS-CoV-2 virus in testing. Here’s a basic overview of how our Airocide units were tested, and the results we saw. For more detail, take a look at the study summary here or reach out to SteriLumen, Inc. for a full copy of the original study results.

Ensuring Reliable Test Results

SteriLumen, Inc. worked with MRIGlobal on a series of tests to determine the efficacy of Airocide air purification products at eliminating aerosolized SARS-CoV-2. Under tightly controlled conditions, both for reliable and repeatable test results and a safe environment for testing staff, they tested the Airocide technology in three distinct ways. They tested an Airocide unit with its integrated particulate filter and an active PCO catalyst, a unit with an active catalyst and no filter, and an unpowered unit as a baseline control test.

Testing Method

To start, MRIGlobal built a specialized system to conduct the tests: a Plexiglas chamber fitted with aerosol generation and sample collection systems inside a sealed protective cabinet. Each unit was tested under the same conditions, for the same amount of time – including the unpowered control unit. Each unit was placed in the chamber, powered on and allowed to warm up for 20 minutes, and the chamber was then filled with aerosolized SARS-CoV-2 for 10 minutes. Samples were collected 5 minutes and 30 seconds after the chamber was filled with the virus, then at regular intervals during the testing period, for up to 30 minutes.

Test Results – Airocide PCO Air Purification and SARS-CoV-2

MRIGlobal’s report shows the reduction or deactivation of SARS-CoV-2 in the tested air. MRIGlobal’s results were reported in a scientific measure known as log reduction. Converted to percentages, the virus was reduced by 99.94% by the Airocide unit with a particulate filter and PCO catalyst within 5 minutes and 30 seconds of operation, and 99.05% by the unit with a catalyst and no filter during the 20-30 minute test period.

Airocide PCO Air Purifiers can Reduce and Deactivate SARS-CoV-2

The results show it clearly, viable SARS-CoV-2 was eliminated or removed from the tested air in significant amounts by the active Airocide units. It echoes similar results we’ve seen with unwanted organic particles like bacteria, other viruses, and fungal spores. When the PCO reactor in an Airocide unit processes air with unwanted organic particles, it’s not just trapping them. With or without filtration, organic particles that enter the reactor are destabilized and destroyed. That means less viable pathogens circulating in your air. Find out more about using PCO to purify the air in your offices and facilities, reach out to our air purification experts and discover Airocide today.